Medicure (OTCMKTS:MCUJF) Trading 2% Higher – Here’s Why

Medicure Inc. (OTCMKTS:MCUJF) shares rose 2% during trading on Monday . The stock traded as high as $0.9011 and last traded at $0.83. Approximately 5,600 shares traded hands during trading, an increase of 4,334% from the average daily volume of 126 shares. The stock had previously closed at $0.8137.

Medicure Price Performance

The company has a debt-to-equity ratio of 0.03, a current ratio of 1.44 and a quick ratio of 1.00. The firm has a market cap of $8.67 million, a PE ratio of -3.46 and a beta of 1.10. The company has a 50 day moving average price of $0.84 and a 200 day moving average price of $0.83.

Medicure (OTCMKTS:MCUJF) last posted its quarterly earnings results on Wednesday, November 19th. The company reported ($0.09) earnings per share for the quarter. The business had revenue of $5.93 million during the quarter. Medicure had a negative net margin of 13.10% and a negative return on equity of 17.91%.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.